期刊文献+

平均生物等效性试验设计方法评价 被引量:2

Comparison of Designs for Establishing Average Bioequivalence
下载PDF
导出
摘要 目的 比较 6种不同的平均生物等效性试验的设计方法的检验效能与所需的样本含量。方法 采用Monte Carlo方法 ,对不同参数组合下 ,6种设计方法的检验效能或样本含量进行模拟。结果  6种平均生物等效性评价试验的设计方法中 ,以 4× 4交叉设计的效率最高 ,而平行组设计和Balaam设计的效率较低。在相同参数组合下 ,所需的样本含量由少到多的顺序为 :4× 4交叉设计、2× 4交叉设计、2× 3交叉设计、2× 2交叉设计、平行组设计和Balaam设计。结论 对于平均生物等效性而言 ,采用 4× 4交叉设计或 2× 4交叉设计效果较好。 Objective To compare the powers and sam ple size requirements of six designs to establish average bioequivalence.Methods Monte-Carlo simulations was used for all six desig ns with difference parameters grid.Results The most powerful design to establishing average bi oequivalence is 4×4 cross-over design.For six designs,the powers of design met hods in descending:4×4 cross-over disign,2×4 cross-over disign,2×3 cross-o ver design,2×2 cross-over design,parallel design and Balaam's design,while the requirement of the number of total sample size is in contrast order.Conclusion The 4×4 and 2×4 cross-over design are recomme nded to establishing average bioequivalence.
出处 《中国卫生统计》 CSCD 北大核心 2004年第6期332-334,共3页 Chinese Journal of Health Statistics
关键词 样本含量 生物等效性试验 检验效能 交叉设计 评价试验 效果 目的 参数组合 平行 结论 Average bioequivalence, Power of test, Sample s ize, Cross-over design, Monte-Carlo
  • 相关文献

参考文献7

  • 1Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. Marcel Dekker, New York, 2000, 125-160.
  • 2Schuirmann DJ. On hypothesis testing to determine of the mean of a normal distribution. Biometrics, 1981,37: 617.
  • 3Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmakinet Biopharm, 1987, 15: 657-680.
  • 4Chow SC, Wang HS. On Sample Size Calculation in Bioequivalence Trials. Journal of Pharmacokinetics and Pharmacodynamics, 2001, 28: 155-169.
  • 5Liu JP et al. On power calculation of Schuirman' s tow one-sided tests procedure in bioequivalence. J Pharmacokinet Biopharm, 1992, 20: 101-104.
  • 6Chen KW et al. Note on Sample Size Determination for Bioequivalence Studies with Higher-Order Crossover Designs. Journal of Pharmacokinetics and Biopharmaceutics, 1997, 25:753-765.
  • 7FDA. Guidance for Industry: Statistical Approaches to Establishing Bioequivelence. Center for Drug Evaluation and Research, Food and Administration. January 2001.

同被引文献60

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部